SlideShare a Scribd company logo
1 of 21
Download to read offline
DIABLISS – WORLD’S FIRST
DIABETIC FRIENDLY CANE SUGAR:
INTRODUCTION & PRODUCT
PERFORMANCE
Diabetes Mellitus
 Diabetes (diabetes mellitus) is classified as a
metabolism disorder
 Types of diabetes – Type 1, Type 2 & Gestational
Diabetes (i.e. during pregnancy). 80% of diabetic
population is type 2.
 In diabetics the body either does not produce
enough insulin, produces no insulin (Type 1), or has
cells that do not respond properly to the insulin the
pancreas produces (type 2).
 Diabetes effects almost every organ in the body
2
Diabetes – A global Epidemic
 India – Diabetic
Capital of the
world!
 A global epidemic
with significant
growth rates of
diabetes projected.
 Diabetes rates
expected to double
world wide in next
20 years
Asia Diabetics % Diabetic North America Diabetics % Diabetic
India 85,923,733 7.1% United States 38,818,308 12.3%
China 60,931,800 4.5% Mexico 11,345,990 10.1%
Pakistan 13,882,616 7.6% Canada 4,066,503 11.6%
Indonesia 10,931,501 4.6% Puerto Rico 459,630 12.4%
Bangladesh 9,303,599 6.1%
Japan 9,297,280 7.3%
Philippines 6,186,636 6.7% Europe Diabetics % Diabetic
Korea, Republic of 5,354,958 9.0% Germany 9,839,160 12.0%
Thailand 5,076,322 7.7% France 6,166,870 9.4%
Malaysia 3,232,940 10.9% Turkey 5,596,426 7.4%
Viet Nam 2,574,620 2.9% Italy 5,235,959 8.8%
Spain 4,112,083 8.7%
Middle East Diabetics % Diabetic Poland 3,583,642 9.3%
Iran 4,714,873 6.1% United Kingdom 3,095,907 4.9%
Saudi Arabia 3,970,642 13.6% Argentina 2,695,740 6.0%
Iraq 2,599,740 7.8% Romania 1,599,676 8.4%
Morocco 2,497,580 7.6% Portugal 1,309,710 12.4%
Syrian Arab Republic 1,828,988 8.3% Netherlands 1,291,968 7.7%
Afghanistan 1,683,007 6.6% Greece 951,737 8.8%
United Arab Emirates 1,008,217 12.2% Austria 950,713 11.2%
Tunisia 916,088 8.5% Czech Republic 914,903 8.7%
Yemen 613,175 2.5%
Israel 567,510 7.1% South America Diabetics % Diabetic
Jordan 471,068 7.5% Brazil 14,258,480 6.0%
Kuwait 386,862 10.8% Colombia 2,255,424 4.8%
Lebanon 332,948 7.7% Venezuela 1,707,820 5.9%
Oman 307,856 11.1% Peru 1,706,608 5.6%
Qatar 254,976 13.3% Cuba 1,228,033 11.0%
Bahrain 177,778 14.4% Guatemala 1,065,248 6.9%
3
Diabetic Prevalence Rates in India
Urban vs. Rural
 General belief among leading medical professionals that WHO and other reports are
grossly underestimating the prevalence of diabetes in India due to poor detection and
prediction rates of diabetes from lifestyle factors
 Rural India has significantly lower Diabetes prevalence rates due to lifestyle factors &
also due to poor detection
4
Diabetics – Recommended Regimen &
Lifestyle Constraints
 Significant lifestyle constraints:
 Severe diet restrictions
 No Sugar
 No Sweets
 Diet low in carbohydrates
 Limited (poor) food alternatives
 Advised to consume 5-6 “mini meals” to manage swings
in blood sugar levels
 Need to closely monitor blood sugar levels
 Exercise 5 times per week
5
What is DiaBliss?
For the first time in the world we are able to render pure cane sugar diabetic
friendly:
 DiaBliss is coming to you after 10 years of R&D and 4 years of product
performance testing among100s of diabetics
 A colorless, odorless and tasteless herbal solution is extracted from 7-17 spices
including Turmeric, Black Pepper, Cinnamon, Ginger, Fenugreek, Gooseberry,
Pomegranate by using only water and no other chemicals or solvents .
 DiaBliss system has limitless versatility: The herbal solution is blended with sugar
makes sugar diabetic friendly and allows glucose present in the blood stream to be
effectively absorbed by the body at a cellular level. The solution when blended
with rice renders carbohydrates diabetic friendly. Along the same lines, fruit based
foods and beverages have been blended with herbal solution to render them
diabetic friendly.
 DiaBliss developed over 20 products which are being launched into retail FMCG
applications in a phased manner.
6
DiaBliss Herbal Solution –
Active Ingredients
 Herbal solution contains a variety of active phytochemicals, including the
flavonoids, terpenoids, lignans, sulfides, polyphenolics, carotenoids, coumarins,
saponins, plant sterols, curcumins, and pthalides.
 Many of these herbs contain potent antioxidant compounds that provide
significant protection against chronic diseases.
 These compounds are known to have variety of health & wellness
characteristics - LDL cholesterol from oxidation, inhibit cyclooxygenase and
lipoxygenase enzymes, improve metabolism, enhance insulin sensitivity, inhibit
lipid peroxidation, or have antiviral or antitumor activity.
7
Fenugreek
Turmeric
Black Pepper
Ginger
Cinnamon
Gooseberry
Pomagranate
Competitive Positioning - Sweeteners
Product Brand Names Composition/
Chemical Name
Manufacturing Process Taste Factors & Cooking Solutions Health Effects Calorific Value
Aspertame Equal, Nutra
Sweet
N-L-aaspartyl-L-
phenylalanine-l-methyl
ester (APM)
Fermentation and sysnthesis with
methanol with metal catalysts
Interacts with some foods and cannot
perfectly replace sugar, not thermally
stable
Aspartame must be avoided by people
with the genetic condition
phenylketonuria(PKU); Recent
packaging indicates not recommended
for children.
4 calories per
gram; 180 times
sweeter than
sugar
Sucralose Splenda,
Sugar Free
4-chloro-4-deoxy-.alpha.-
D-galactopyranosyl 1.6-
dichloro-1.6-dideoxy-
.beta.-D-fructo-
furanoside
Five Step Chemical Process
including chlorination of sucrose,
followed by high temperature, low
pH process for final conversion to
sucralose
There is still a distinct chemical taste
especially when products are used to
make sweets. Thermally stable and can
be used in almost all categories of foods &
beverages.
FDA & WHO evaluated over 100 studies
over 20 years and concluded the product
is generally safe. Recent packaging
indicates not recommended for
children.
No calorific
content
Saccharin Sweet' n Low,
Sweet Twin, and
Necta Sweet
2H-1λ6,2-benzothiazol-
1,1,3-trione
Two chemical synthesis processes Bitter after taste. Not thermally stable. Suspected Carcinogen (bladder cancer). 1 calorie per
gram, 10x
sweeter
Stevia Truvia, PureVia,
SweetLeaf
Sweetening ingredient -
Steviol glycosides. Class
of Compaounds fund in
Stevia plant leaf.
Minimal Processing for dark
colored stevia extracts. Crystalline
forms involves some level of
chemcal processing
Some level of bitter after taste; Can be
used for cooking and baking
Approved by FDA; Banned in some
European countries
4 calories per
gram; 200-400
times sweeter
than sugar
Levulose Dezire D-Frustose Some level of bitter after taste; Can be
used for cooking and baking; Indian
sweets have a distinct after taste
Fructose based products such as corn
syrup have been approved by FDA.
4 calories per
gram; Lower
Glycemic Index
than Sugar
Herbal Cane Sugar DiaBliss Cane Sugar blended with
herbal extracts
A colourless, tasteless and
odourless extract from 7 common
herbs and spices; Only water used
in preparation of herbal solution.
Only product that can claim exact same
taste of sugar; Thermally stable and can be
used in all categories of foods similar to
Sucralose.
HbA1c, Fasting and Post Pradial levels
show decreasing trends; Analysis and
animal studies indicate product is safe
for human consumption
4 calories per
gram; Lower
Glycemic Index
than Sugar
8
DiaBliss – Key Product Attributes
 Natural Taste of Pure Cane Sugar with no after taste characteristics of sweeteners
 High degree of product versatility in terms of usage in baking, cooking, low and
high temperature, wide pH ranges.
 100% Natural - No chemicals in herbal extraction, only uses water in extraction
 Only product that provides sugar, carbohydrate and fructose management system
thereby providing a complete and integrated approach to diabetic friendly foods
 Content analysis, acute and sub-acute animal studies and histopathology studies on
animals indicate product is safe for human consumption.
 Product showing positive efficacy in terms on long term blood sugar control (ie lower
levels of HbA1c, Fasting and Post prandial levels) in type 1 and type 2 diabetics
based on consumption periods from three months to three years.
9
Overall Process
Water based
extraction of
molecular values
Herbs & Spices
Herbal Extract
Herbal
Solution
Blending
Ageing/
Drying
Packaging
Sugar
(or Salt, Rice)
Primary Products
DiaBliss Sugar
DiaBliss Salt
DiaBliss Rice
Herbal
Solution
Blending Processing Packaging
Ingredients
Derivative Products
DiaBliss Beverages(Lemon Tea, Lemon Juice, Instant Tea & Coffee Mix)
DiaBliss Prepared Foods ( Mixed Fruit Jam, Ketchup, Ravva Laddu Mix, Kesari Bath,
Gulab Jamun Mix, etc)
DiaBliss Cereals (Multigrain Porridge)
DiaBliss Chocolates (Dark, Milk & Filled)
DiaBliss Ice Cream Mixes (Vanilla, Mango)
Institutional Products
(Bulk Packaging of DiaBliss Sugar & other products)
Sweet Chains
Bakeries
Hotels & Institutional
Food Companies
Beverage Companies
10
Product Performance Summary
 Product Characterization @ SGS
labs, Chennai
 Trials @ Sugen Life Sciences,
Tirupati
– Acute & Sub-Acute Toxicity studies
 Summary of Product Usage &
Customer Testimonials
– Short Term Trials
– Long Term Trials
 Product composition is safe for human
consumption based on heavy metals & pesticide
analyses.
 No detrimental impact on animals health
parameters. Histopathological studies indicated
no organ impact when subject to accelerated
usage of product
 GTT data indicates DiaBliss Sugar can be
classified as low glycemic index product
 Extended GTT results with diabetic subjects
indicated excellent blood sugar control even with
high loading of DiaBliss sugar.
 Data from diabetics who consumed product for
periods between 3 months to 36 months indicates
product is providing significant health benefits to
diabetics
11
DiaBliss Tackles all Metabolic Pathways
1. Starch to Sugar Conversion
2. Glucose Absorption
3. Glucose Tissue Uptake
4. Fat Reduction
5. Glucose Homeostasis*
6. Insulin Release
7. Insulin Sensitivity
* Glucose Homeostasis: the balance of insulin and glucagon to maintain blood
glucose; Glucagon: a fall in blood glucose increases the release of glucagon from the
pancreas to promote glucose production.
12
Acute Oral Toxicity with Wistar Rats
Sub-Acute Oral Toxicity with Wistar Rats
Typical HbA1c Profiles
 Effective for Type 1 & Type 2
diabetics
 15-50% reduction in HbA1c levels
 Subjects report energetic feeling &
improved general wellness
Glycemic Index
 Higher rate of metabolism
 Low Glycemic Index Food (GI = 53 vs.
60 for normal sugar & 100 for
glucose)
15
Extended Glucose Tolerance Tests
Conducted with diabetics
 Excellent metabolism of
sugar by diabetics.
 Sugar levels of normal
diabetics at or below
fasting levels in three
hours.
 Two chronic alcoholics
(subjects 2 & 5) could
not metabolise at
satisfactory rates as
their liver and
pancreatic functions
already impeded.
 Blood Sugar levels
dropped below fasting
levels for 70% of the
diabetics tested
indicating excellent
metabolic response
16
Fasting, PP & HbA1c
Type 1 Diabetic
 Type 1 diabetic, Age 58
 9 months on DiaBliss Herbal cane sugar
 40% reduction in HbA1c
0
50
100
150
200
250
4/3/2012 14/8/2012 15/9/2012 17/9/2012
BloodSugarLevels,mg/dl
Type 1 Diabetic, Female, age 58 - Fasting & PP Profiles
Fasting
PP
Started consuming DiaBliss Herbal Cane Sugar
for Tea & Coffee
6
6.5
7
7.5
8
8.5
9
4/3/2012 6/6/2012 14/8/2012 17/9/2012
HbA1c
Type 1 Diabetic, Female, age 58 - HbA1c Profile
Started consuming DiaBliss
Herbal Cane Sugar for
Tea & Coffee
* Blood Sugar levels measured at Mohan Diagnostics, Madurai
17
Subject underwent
Fistula Operation
Fasting, PP & HbA1c
Type 2 Diabetic
 Type 2 Diabetic, Age 63
 18 months on DiaBliss herbal cane sugar
 Lowered medication by 50%; Stabilized Fasting, PP & HbA1c swings
* Blood Sugar levels measured at Hi Tech Labs, Vadapalani, Chennai & Precision Labs, Adyar, Chennai
18
Juvenile Diabetic
 8 year old juvenile
diabetic
 Two years on
DiaBliss Sugar
 Major lifestyle
improvement
 Able to go to
school full-time
 Able to enjoy all
kinds of foods &
sweets
 Gaining body
weight without
significant increase
in insulin dosage
 45% reduction in
HbA1c levels
* Blood Sugar levels measured at Priya Diagnostics, Besant Nagar, Chennai
19
Summary
 For the first time in the world DiaBliss has been successful in making cane sugar
diabetic friendly
 DiaBliss system provides unlimited food choices for diabetics, pre-diabetics and
wellness solutions for entire family
 DiaBliss Sugar has been extensively tested and found to be safe for human
consumption.
 Hundreds of diabetcs ranging in age from 8 to 82 (type 1, type 2) have
consumed DiaBliss Sugar for periods ranging from 3 months to 3+ years;
HbA1c, Fasting and PP levels tending to show lowering trends
 DiaBliss has over 20 diabetic friendly and general wellness products spanning
various categories including primary foods, cereals, beverages, prepared foods,
chocolates, ice creams which will be introduced into the market in a sequential
manner.
THANK YOU
Contact:
www.diabliss.com
DiaBliss Consumer Products Pvt Ltd
1/283 ‘Shripuram’
Shripuram Road
Thoraipakkam
Chennai – 60097
Tamil Nadu
VR. Ramanathan, CEO
VRR@diabliss.com
Tel: +91-9840427966
Siva Vallabhaneni, COO
Shiv@diabliss.com
Tel: +91-7760980631
21

More Related Content

Recently uploaded

MedMatch: Your Health, Our Mission. Pitch deck.
MedMatch: Your Health, Our Mission. Pitch deck.MedMatch: Your Health, Our Mission. Pitch deck.
MedMatch: Your Health, Our Mission. Pitch deck.whalesdesign
 
Clinical Research Informatics Year-in-Review 2024
Clinical Research Informatics Year-in-Review 2024Clinical Research Informatics Year-in-Review 2024
Clinical Research Informatics Year-in-Review 2024Peter Embi
 
SGK RỐI LOẠN KALI MÁU CỰC KỲ QUAN TRỌNG.pdf
SGK RỐI LOẠN KALI MÁU CỰC KỲ QUAN TRỌNG.pdfSGK RỐI LOẠN KALI MÁU CỰC KỲ QUAN TRỌNG.pdf
SGK RỐI LOẠN KALI MÁU CỰC KỲ QUAN TRỌNG.pdfHongBiThi1
 
DNA nucleotides Blast in NCBI and Phylogeny using MEGA Xi.pptx
DNA nucleotides Blast in NCBI and Phylogeny using MEGA Xi.pptxDNA nucleotides Blast in NCBI and Phylogeny using MEGA Xi.pptx
DNA nucleotides Blast in NCBI and Phylogeny using MEGA Xi.pptxMAsifAhmad
 
Pharmacokinetic Models by Dr. Ram D. Bawankar.ppt
Pharmacokinetic Models by Dr. Ram D.  Bawankar.pptPharmacokinetic Models by Dr. Ram D.  Bawankar.ppt
Pharmacokinetic Models by Dr. Ram D. Bawankar.pptRamDBawankar1
 
BENIGN BREAST DISEASE
BENIGN BREAST DISEASE BENIGN BREAST DISEASE
BENIGN BREAST DISEASE Mamatha Lakka
 
Generative AI in Health Care a scoping review and a persoanl experience.
Generative AI in Health Care a scoping review and a persoanl experience.Generative AI in Health Care a scoping review and a persoanl experience.
Generative AI in Health Care a scoping review and a persoanl experience.Vaikunthan Rajaratnam
 
Basic structure of hair and hair growth cycle.pptx
Basic structure of hair and hair growth cycle.pptxBasic structure of hair and hair growth cycle.pptx
Basic structure of hair and hair growth cycle.pptxkomalt2001
 
Different drug regularity bodies in different countries.
Different drug regularity bodies in different countries.Different drug regularity bodies in different countries.
Different drug regularity bodies in different countries.kishan singh tomar
 
ANATOMICAL FAETURES OF BONES FOR NURSING STUDENTS .pptx
ANATOMICAL FAETURES OF BONES  FOR NURSING STUDENTS .pptxANATOMICAL FAETURES OF BONES  FOR NURSING STUDENTS .pptx
ANATOMICAL FAETURES OF BONES FOR NURSING STUDENTS .pptxWINCY THIRUMURUGAN
 
pA2 value, Schild plot and pD2 values- applications in pharmacology
pA2 value, Schild plot and pD2 values- applications in pharmacologypA2 value, Schild plot and pD2 values- applications in pharmacology
pA2 value, Schild plot and pD2 values- applications in pharmacologyDeepakDaniel9
 
High-Performance Thin-Layer Chromatography (HPTLC)
High-Performance Thin-Layer Chromatography (HPTLC)High-Performance Thin-Layer Chromatography (HPTLC)
High-Performance Thin-Layer Chromatography (HPTLC)kishan singh tomar
 
SGK RỐI LOẠN TOAN KIỀM ĐHYHN RẤT HAY VÀ ĐẶC SẮC.pdf
SGK RỐI LOẠN TOAN KIỀM ĐHYHN RẤT HAY VÀ ĐẶC SẮC.pdfSGK RỐI LOẠN TOAN KIỀM ĐHYHN RẤT HAY VÀ ĐẶC SẮC.pdf
SGK RỐI LOẠN TOAN KIỀM ĐHYHN RẤT HAY VÀ ĐẶC SẮC.pdfHongBiThi1
 
Using Data Visualization in Public Health Communications
Using Data Visualization in Public Health CommunicationsUsing Data Visualization in Public Health Communications
Using Data Visualization in Public Health Communicationskatiequigley33
 
Adenomyosis or Fibroid- making right diagnosis
Adenomyosis or Fibroid- making right diagnosisAdenomyosis or Fibroid- making right diagnosis
Adenomyosis or Fibroid- making right diagnosisSujoy Dasgupta
 
ayurvedic formulations herbal drug technologyppt
ayurvedic formulations herbal drug technologypptayurvedic formulations herbal drug technologyppt
ayurvedic formulations herbal drug technologypptPradnya Wadekar
 

Recently uploaded (20)

MedMatch: Your Health, Our Mission. Pitch deck.
MedMatch: Your Health, Our Mission. Pitch deck.MedMatch: Your Health, Our Mission. Pitch deck.
MedMatch: Your Health, Our Mission. Pitch deck.
 
Immune labs basics part 1 acute phase reactants ESR, CRP Ahmed Yehia Ismaeel,...
Immune labs basics part 1 acute phase reactants ESR, CRP Ahmed Yehia Ismaeel,...Immune labs basics part 1 acute phase reactants ESR, CRP Ahmed Yehia Ismaeel,...
Immune labs basics part 1 acute phase reactants ESR, CRP Ahmed Yehia Ismaeel,...
 
Clinical Research Informatics Year-in-Review 2024
Clinical Research Informatics Year-in-Review 2024Clinical Research Informatics Year-in-Review 2024
Clinical Research Informatics Year-in-Review 2024
 
Biologic therapy ice breaking in rheumatology, Case based approach with appli...
Biologic therapy ice breaking in rheumatology, Case based approach with appli...Biologic therapy ice breaking in rheumatology, Case based approach with appli...
Biologic therapy ice breaking in rheumatology, Case based approach with appli...
 
SGK RỐI LOẠN KALI MÁU CỰC KỲ QUAN TRỌNG.pdf
SGK RỐI LOẠN KALI MÁU CỰC KỲ QUAN TRỌNG.pdfSGK RỐI LOẠN KALI MÁU CỰC KỲ QUAN TRỌNG.pdf
SGK RỐI LOẠN KALI MÁU CỰC KỲ QUAN TRỌNG.pdf
 
DNA nucleotides Blast in NCBI and Phylogeny using MEGA Xi.pptx
DNA nucleotides Blast in NCBI and Phylogeny using MEGA Xi.pptxDNA nucleotides Blast in NCBI and Phylogeny using MEGA Xi.pptx
DNA nucleotides Blast in NCBI and Phylogeny using MEGA Xi.pptx
 
Pharmacokinetic Models by Dr. Ram D. Bawankar.ppt
Pharmacokinetic Models by Dr. Ram D.  Bawankar.pptPharmacokinetic Models by Dr. Ram D.  Bawankar.ppt
Pharmacokinetic Models by Dr. Ram D. Bawankar.ppt
 
BENIGN BREAST DISEASE
BENIGN BREAST DISEASE BENIGN BREAST DISEASE
BENIGN BREAST DISEASE
 
Generative AI in Health Care a scoping review and a persoanl experience.
Generative AI in Health Care a scoping review and a persoanl experience.Generative AI in Health Care a scoping review and a persoanl experience.
Generative AI in Health Care a scoping review and a persoanl experience.
 
Basic structure of hair and hair growth cycle.pptx
Basic structure of hair and hair growth cycle.pptxBasic structure of hair and hair growth cycle.pptx
Basic structure of hair and hair growth cycle.pptx
 
Different drug regularity bodies in different countries.
Different drug regularity bodies in different countries.Different drug regularity bodies in different countries.
Different drug regularity bodies in different countries.
 
ANATOMICAL FAETURES OF BONES FOR NURSING STUDENTS .pptx
ANATOMICAL FAETURES OF BONES  FOR NURSING STUDENTS .pptxANATOMICAL FAETURES OF BONES  FOR NURSING STUDENTS .pptx
ANATOMICAL FAETURES OF BONES FOR NURSING STUDENTS .pptx
 
GOUT UPDATE AHMED YEHIA 2024, case based approach with application of the lat...
GOUT UPDATE AHMED YEHIA 2024, case based approach with application of the lat...GOUT UPDATE AHMED YEHIA 2024, case based approach with application of the lat...
GOUT UPDATE AHMED YEHIA 2024, case based approach with application of the lat...
 
pA2 value, Schild plot and pD2 values- applications in pharmacology
pA2 value, Schild plot and pD2 values- applications in pharmacologypA2 value, Schild plot and pD2 values- applications in pharmacology
pA2 value, Schild plot and pD2 values- applications in pharmacology
 
High-Performance Thin-Layer Chromatography (HPTLC)
High-Performance Thin-Layer Chromatography (HPTLC)High-Performance Thin-Layer Chromatography (HPTLC)
High-Performance Thin-Layer Chromatography (HPTLC)
 
SGK RỐI LOẠN TOAN KIỀM ĐHYHN RẤT HAY VÀ ĐẶC SẮC.pdf
SGK RỐI LOẠN TOAN KIỀM ĐHYHN RẤT HAY VÀ ĐẶC SẮC.pdfSGK RỐI LOẠN TOAN KIỀM ĐHYHN RẤT HAY VÀ ĐẶC SẮC.pdf
SGK RỐI LOẠN TOAN KIỀM ĐHYHN RẤT HAY VÀ ĐẶC SẮC.pdf
 
Using Data Visualization in Public Health Communications
Using Data Visualization in Public Health CommunicationsUsing Data Visualization in Public Health Communications
Using Data Visualization in Public Health Communications
 
American College of physicians ACP high value care recommendations in rheumat...
American College of physicians ACP high value care recommendations in rheumat...American College of physicians ACP high value care recommendations in rheumat...
American College of physicians ACP high value care recommendations in rheumat...
 
Adenomyosis or Fibroid- making right diagnosis
Adenomyosis or Fibroid- making right diagnosisAdenomyosis or Fibroid- making right diagnosis
Adenomyosis or Fibroid- making right diagnosis
 
ayurvedic formulations herbal drug technologyppt
ayurvedic formulations herbal drug technologypptayurvedic formulations herbal drug technologyppt
ayurvedic formulations herbal drug technologyppt
 

Diabliss - World's First Diabetic Friendly Cane Sugar

  • 1. DIABLISS – WORLD’S FIRST DIABETIC FRIENDLY CANE SUGAR: INTRODUCTION & PRODUCT PERFORMANCE
  • 2. Diabetes Mellitus  Diabetes (diabetes mellitus) is classified as a metabolism disorder  Types of diabetes – Type 1, Type 2 & Gestational Diabetes (i.e. during pregnancy). 80% of diabetic population is type 2.  In diabetics the body either does not produce enough insulin, produces no insulin (Type 1), or has cells that do not respond properly to the insulin the pancreas produces (type 2).  Diabetes effects almost every organ in the body 2
  • 3. Diabetes – A global Epidemic  India – Diabetic Capital of the world!  A global epidemic with significant growth rates of diabetes projected.  Diabetes rates expected to double world wide in next 20 years Asia Diabetics % Diabetic North America Diabetics % Diabetic India 85,923,733 7.1% United States 38,818,308 12.3% China 60,931,800 4.5% Mexico 11,345,990 10.1% Pakistan 13,882,616 7.6% Canada 4,066,503 11.6% Indonesia 10,931,501 4.6% Puerto Rico 459,630 12.4% Bangladesh 9,303,599 6.1% Japan 9,297,280 7.3% Philippines 6,186,636 6.7% Europe Diabetics % Diabetic Korea, Republic of 5,354,958 9.0% Germany 9,839,160 12.0% Thailand 5,076,322 7.7% France 6,166,870 9.4% Malaysia 3,232,940 10.9% Turkey 5,596,426 7.4% Viet Nam 2,574,620 2.9% Italy 5,235,959 8.8% Spain 4,112,083 8.7% Middle East Diabetics % Diabetic Poland 3,583,642 9.3% Iran 4,714,873 6.1% United Kingdom 3,095,907 4.9% Saudi Arabia 3,970,642 13.6% Argentina 2,695,740 6.0% Iraq 2,599,740 7.8% Romania 1,599,676 8.4% Morocco 2,497,580 7.6% Portugal 1,309,710 12.4% Syrian Arab Republic 1,828,988 8.3% Netherlands 1,291,968 7.7% Afghanistan 1,683,007 6.6% Greece 951,737 8.8% United Arab Emirates 1,008,217 12.2% Austria 950,713 11.2% Tunisia 916,088 8.5% Czech Republic 914,903 8.7% Yemen 613,175 2.5% Israel 567,510 7.1% South America Diabetics % Diabetic Jordan 471,068 7.5% Brazil 14,258,480 6.0% Kuwait 386,862 10.8% Colombia 2,255,424 4.8% Lebanon 332,948 7.7% Venezuela 1,707,820 5.9% Oman 307,856 11.1% Peru 1,706,608 5.6% Qatar 254,976 13.3% Cuba 1,228,033 11.0% Bahrain 177,778 14.4% Guatemala 1,065,248 6.9% 3
  • 4. Diabetic Prevalence Rates in India Urban vs. Rural  General belief among leading medical professionals that WHO and other reports are grossly underestimating the prevalence of diabetes in India due to poor detection and prediction rates of diabetes from lifestyle factors  Rural India has significantly lower Diabetes prevalence rates due to lifestyle factors & also due to poor detection 4
  • 5. Diabetics – Recommended Regimen & Lifestyle Constraints  Significant lifestyle constraints:  Severe diet restrictions  No Sugar  No Sweets  Diet low in carbohydrates  Limited (poor) food alternatives  Advised to consume 5-6 “mini meals” to manage swings in blood sugar levels  Need to closely monitor blood sugar levels  Exercise 5 times per week 5
  • 6. What is DiaBliss? For the first time in the world we are able to render pure cane sugar diabetic friendly:  DiaBliss is coming to you after 10 years of R&D and 4 years of product performance testing among100s of diabetics  A colorless, odorless and tasteless herbal solution is extracted from 7-17 spices including Turmeric, Black Pepper, Cinnamon, Ginger, Fenugreek, Gooseberry, Pomegranate by using only water and no other chemicals or solvents .  DiaBliss system has limitless versatility: The herbal solution is blended with sugar makes sugar diabetic friendly and allows glucose present in the blood stream to be effectively absorbed by the body at a cellular level. The solution when blended with rice renders carbohydrates diabetic friendly. Along the same lines, fruit based foods and beverages have been blended with herbal solution to render them diabetic friendly.  DiaBliss developed over 20 products which are being launched into retail FMCG applications in a phased manner. 6
  • 7. DiaBliss Herbal Solution – Active Ingredients  Herbal solution contains a variety of active phytochemicals, including the flavonoids, terpenoids, lignans, sulfides, polyphenolics, carotenoids, coumarins, saponins, plant sterols, curcumins, and pthalides.  Many of these herbs contain potent antioxidant compounds that provide significant protection against chronic diseases.  These compounds are known to have variety of health & wellness characteristics - LDL cholesterol from oxidation, inhibit cyclooxygenase and lipoxygenase enzymes, improve metabolism, enhance insulin sensitivity, inhibit lipid peroxidation, or have antiviral or antitumor activity. 7 Fenugreek Turmeric Black Pepper Ginger Cinnamon Gooseberry Pomagranate
  • 8. Competitive Positioning - Sweeteners Product Brand Names Composition/ Chemical Name Manufacturing Process Taste Factors & Cooking Solutions Health Effects Calorific Value Aspertame Equal, Nutra Sweet N-L-aaspartyl-L- phenylalanine-l-methyl ester (APM) Fermentation and sysnthesis with methanol with metal catalysts Interacts with some foods and cannot perfectly replace sugar, not thermally stable Aspartame must be avoided by people with the genetic condition phenylketonuria(PKU); Recent packaging indicates not recommended for children. 4 calories per gram; 180 times sweeter than sugar Sucralose Splenda, Sugar Free 4-chloro-4-deoxy-.alpha.- D-galactopyranosyl 1.6- dichloro-1.6-dideoxy- .beta.-D-fructo- furanoside Five Step Chemical Process including chlorination of sucrose, followed by high temperature, low pH process for final conversion to sucralose There is still a distinct chemical taste especially when products are used to make sweets. Thermally stable and can be used in almost all categories of foods & beverages. FDA & WHO evaluated over 100 studies over 20 years and concluded the product is generally safe. Recent packaging indicates not recommended for children. No calorific content Saccharin Sweet' n Low, Sweet Twin, and Necta Sweet 2H-1λ6,2-benzothiazol- 1,1,3-trione Two chemical synthesis processes Bitter after taste. Not thermally stable. Suspected Carcinogen (bladder cancer). 1 calorie per gram, 10x sweeter Stevia Truvia, PureVia, SweetLeaf Sweetening ingredient - Steviol glycosides. Class of Compaounds fund in Stevia plant leaf. Minimal Processing for dark colored stevia extracts. Crystalline forms involves some level of chemcal processing Some level of bitter after taste; Can be used for cooking and baking Approved by FDA; Banned in some European countries 4 calories per gram; 200-400 times sweeter than sugar Levulose Dezire D-Frustose Some level of bitter after taste; Can be used for cooking and baking; Indian sweets have a distinct after taste Fructose based products such as corn syrup have been approved by FDA. 4 calories per gram; Lower Glycemic Index than Sugar Herbal Cane Sugar DiaBliss Cane Sugar blended with herbal extracts A colourless, tasteless and odourless extract from 7 common herbs and spices; Only water used in preparation of herbal solution. Only product that can claim exact same taste of sugar; Thermally stable and can be used in all categories of foods similar to Sucralose. HbA1c, Fasting and Post Pradial levels show decreasing trends; Analysis and animal studies indicate product is safe for human consumption 4 calories per gram; Lower Glycemic Index than Sugar 8
  • 9. DiaBliss – Key Product Attributes  Natural Taste of Pure Cane Sugar with no after taste characteristics of sweeteners  High degree of product versatility in terms of usage in baking, cooking, low and high temperature, wide pH ranges.  100% Natural - No chemicals in herbal extraction, only uses water in extraction  Only product that provides sugar, carbohydrate and fructose management system thereby providing a complete and integrated approach to diabetic friendly foods  Content analysis, acute and sub-acute animal studies and histopathology studies on animals indicate product is safe for human consumption.  Product showing positive efficacy in terms on long term blood sugar control (ie lower levels of HbA1c, Fasting and Post prandial levels) in type 1 and type 2 diabetics based on consumption periods from three months to three years. 9
  • 10. Overall Process Water based extraction of molecular values Herbs & Spices Herbal Extract Herbal Solution Blending Ageing/ Drying Packaging Sugar (or Salt, Rice) Primary Products DiaBliss Sugar DiaBliss Salt DiaBliss Rice Herbal Solution Blending Processing Packaging Ingredients Derivative Products DiaBliss Beverages(Lemon Tea, Lemon Juice, Instant Tea & Coffee Mix) DiaBliss Prepared Foods ( Mixed Fruit Jam, Ketchup, Ravva Laddu Mix, Kesari Bath, Gulab Jamun Mix, etc) DiaBliss Cereals (Multigrain Porridge) DiaBliss Chocolates (Dark, Milk & Filled) DiaBliss Ice Cream Mixes (Vanilla, Mango) Institutional Products (Bulk Packaging of DiaBliss Sugar & other products) Sweet Chains Bakeries Hotels & Institutional Food Companies Beverage Companies 10
  • 11. Product Performance Summary  Product Characterization @ SGS labs, Chennai  Trials @ Sugen Life Sciences, Tirupati – Acute & Sub-Acute Toxicity studies  Summary of Product Usage & Customer Testimonials – Short Term Trials – Long Term Trials  Product composition is safe for human consumption based on heavy metals & pesticide analyses.  No detrimental impact on animals health parameters. Histopathological studies indicated no organ impact when subject to accelerated usage of product  GTT data indicates DiaBliss Sugar can be classified as low glycemic index product  Extended GTT results with diabetic subjects indicated excellent blood sugar control even with high loading of DiaBliss sugar.  Data from diabetics who consumed product for periods between 3 months to 36 months indicates product is providing significant health benefits to diabetics 11
  • 12. DiaBliss Tackles all Metabolic Pathways 1. Starch to Sugar Conversion 2. Glucose Absorption 3. Glucose Tissue Uptake 4. Fat Reduction 5. Glucose Homeostasis* 6. Insulin Release 7. Insulin Sensitivity * Glucose Homeostasis: the balance of insulin and glucagon to maintain blood glucose; Glucagon: a fall in blood glucose increases the release of glucagon from the pancreas to promote glucose production. 12
  • 13. Acute Oral Toxicity with Wistar Rats
  • 14. Sub-Acute Oral Toxicity with Wistar Rats
  • 15. Typical HbA1c Profiles  Effective for Type 1 & Type 2 diabetics  15-50% reduction in HbA1c levels  Subjects report energetic feeling & improved general wellness Glycemic Index  Higher rate of metabolism  Low Glycemic Index Food (GI = 53 vs. 60 for normal sugar & 100 for glucose) 15
  • 16. Extended Glucose Tolerance Tests Conducted with diabetics  Excellent metabolism of sugar by diabetics.  Sugar levels of normal diabetics at or below fasting levels in three hours.  Two chronic alcoholics (subjects 2 & 5) could not metabolise at satisfactory rates as their liver and pancreatic functions already impeded.  Blood Sugar levels dropped below fasting levels for 70% of the diabetics tested indicating excellent metabolic response 16
  • 17. Fasting, PP & HbA1c Type 1 Diabetic  Type 1 diabetic, Age 58  9 months on DiaBliss Herbal cane sugar  40% reduction in HbA1c 0 50 100 150 200 250 4/3/2012 14/8/2012 15/9/2012 17/9/2012 BloodSugarLevels,mg/dl Type 1 Diabetic, Female, age 58 - Fasting & PP Profiles Fasting PP Started consuming DiaBliss Herbal Cane Sugar for Tea & Coffee 6 6.5 7 7.5 8 8.5 9 4/3/2012 6/6/2012 14/8/2012 17/9/2012 HbA1c Type 1 Diabetic, Female, age 58 - HbA1c Profile Started consuming DiaBliss Herbal Cane Sugar for Tea & Coffee * Blood Sugar levels measured at Mohan Diagnostics, Madurai 17 Subject underwent Fistula Operation
  • 18. Fasting, PP & HbA1c Type 2 Diabetic  Type 2 Diabetic, Age 63  18 months on DiaBliss herbal cane sugar  Lowered medication by 50%; Stabilized Fasting, PP & HbA1c swings * Blood Sugar levels measured at Hi Tech Labs, Vadapalani, Chennai & Precision Labs, Adyar, Chennai 18
  • 19. Juvenile Diabetic  8 year old juvenile diabetic  Two years on DiaBliss Sugar  Major lifestyle improvement  Able to go to school full-time  Able to enjoy all kinds of foods & sweets  Gaining body weight without significant increase in insulin dosage  45% reduction in HbA1c levels * Blood Sugar levels measured at Priya Diagnostics, Besant Nagar, Chennai 19
  • 20. Summary  For the first time in the world DiaBliss has been successful in making cane sugar diabetic friendly  DiaBliss system provides unlimited food choices for diabetics, pre-diabetics and wellness solutions for entire family  DiaBliss Sugar has been extensively tested and found to be safe for human consumption.  Hundreds of diabetcs ranging in age from 8 to 82 (type 1, type 2) have consumed DiaBliss Sugar for periods ranging from 3 months to 3+ years; HbA1c, Fasting and PP levels tending to show lowering trends  DiaBliss has over 20 diabetic friendly and general wellness products spanning various categories including primary foods, cereals, beverages, prepared foods, chocolates, ice creams which will be introduced into the market in a sequential manner.
  • 21. THANK YOU Contact: www.diabliss.com DiaBliss Consumer Products Pvt Ltd 1/283 ‘Shripuram’ Shripuram Road Thoraipakkam Chennai – 60097 Tamil Nadu VR. Ramanathan, CEO VRR@diabliss.com Tel: +91-9840427966 Siva Vallabhaneni, COO Shiv@diabliss.com Tel: +91-7760980631 21